Is Olema Pharmaceuticals Inc (OLMA) overvalued? · $824.6M cap
Olema Pharmaceuticals Inc (OLMA) is a biotechnology company listed on NASDAQ.
This page asks whether Olema Pharmaceuticals Inc (OLMA) looks expensive on cached numbers — not a short thesis.
No cached income statement for OLMA, so there is no earnings base to call rich or cheap.
OLMA currently screens at market cap $824.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next OLMA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the OLMA stock page for the full model, not this heading.
Not investment advice.